Other genes that are associated with poor prognosis and tumor progression, such as ODC1, ERN1, and ETS2, were also downregulated primarily in the samples treated with Se-E2, Se-K2 and Se-C3 [48,49,50]. The gene discussed is ETS2; the disease is neoplasm.